Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 6135739, 2 pages

Harnessing Oxidative Stress as an Innovative Target for Cancer Therapy

1Department of Oncology, University of Alberta, Edmonton, AB, Canada
2Department of Physiology, University of Lausanne, Lausanne, Switzerland
3Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
4Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB, Canada
5Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada

Correspondence should be addressed to Spencer B. Gibson; ac.abotinamu@nosbig.recneps

Received 18 December 2017; Accepted 20 December 2017; Published 24 May 2018

Copyright © 2018 Lynne Postovit et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar
  2. M. B. Azad, Y. Chen, and S. B. Gibson, “Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment,” Antioxidants & Redox Signaling, vol. 11, no. 4, pp. 777–790, 2009. View at Publisher · View at Google Scholar
  3. J. N. Moloney and T. G. Cotter, “ROS signalling in the biology of cancer,” Seminars in Cell & Developmental Biology, no. 16, pp. 30383-30384, 2017. View at Publisher · View at Google Scholar
  4. H. Xie and M. C. Simon, “Oxygen availability and metabolic reprogramming in cancer,” Journal of Biological Chemistry, vol. 292, no. 41, pp. 16825–16832, 2017. View at Publisher · View at Google Scholar
  5. M. K. L. Fung and G. C.-F. Chan, “Drug-induced amino acid deprivation as strategy for cancer therapy,” Journal of Hematology & Oncology, vol. 10, no. 1, p. 144, 2017. View at Publisher · View at Google Scholar
  6. A. Kaeidi, B. Rasoulian, Z. Hajializadeh, S. Pourkhodadad, and M. Rezaei, “Cisplatin toxicity reduced in human cultured renal tubular cells by oxygen pretreatment,” Renal Failure, vol. 35, no. 10, pp. 1382–1386, 2013. View at Publisher · View at Google Scholar
  7. A. Monteiro, R. Hill, G. Pilkington, and P. Madureira, “The role of hypoxia in glioblastoma invasion,” Cell, vol. 6, no. 4, 2017. View at Publisher · View at Google Scholar
  8. L. K. Brady, H. Wang, C. M. Radens et al., “Transcriptome analysis of hypoxic cancer cells uncovers intron retention in EIF2B5 as a mechanism to inhibit translation,” PLoS Biology, vol. 15, no. 9, article e2002623, 2017. View at Publisher · View at Google Scholar